Tredegar (TG) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
2 Dec, 2025Executive summary
The annual meeting will be held virtually on May 8, 2025, with shareholders voting on director elections, executive compensation, and auditor ratification.
Shareholders can vote online, by phone, mail, or during the virtual meeting, with detailed instructions provided.
The Board recommends voting in favor of all proposals, including the election of seven directors, a non-binding say-on-pay vote, and ratification of KPMG as auditor.
Voting matters and shareholder proposals
Proposals include electing seven directors, an advisory vote on executive compensation, and ratifying KPMG as auditor.
Shareholders may submit proposals or director nominations for future meetings, following specific bylaw requirements.
The Board recommends voting FOR all proposals.
Board of directors and corporate governance
The Board consists of seven directors, six of whom are independent, with diverse backgrounds and an average tenure of 10 years.
Separate CEO and Chairman roles, annual board evaluations, and robust stock ownership guidelines are in place.
Committees include Audit, Executive Compensation, and Nominating and Governance, all composed of independent directors.
Board succession planning and refreshment are ongoing priorities.
Latest events from Tredegar
- 2025 saw robust earnings growth, improved leverage, and strong segment performance amid tariff challenges.TG
Q4 202511 Mar 2026 - Virtual meeting on May 9, 2025, to vote on directors, pay, and auditor ratification.TG
Proxy Filing2 Dec 2025 - Q3 2025 delivered strong profit and EBITDA growth, led by Aluminum Extrusions and lower net debt.TG
Q3 20252 Dec 2025 - Net income and EBITDA fell in Q2 2025 as tariffs and inefficiencies pressured results.TG
Q2 20258 Oct 2025 - Improved Q3 results, Terphane sale, and lower leverage amid ongoing margin pressures.TG
Q3 202413 Jun 2025 - Q2 2024 net income rebounded to $8.8M with broad EBITDA gains and key regulatory decisions ahead.TG
Q2 202413 Jun 2025 - Net income jumped to $10.1M as Terphane sale and tariffs boosted results despite margin pressure.TG
Q1 20256 Jun 2025 - Tredegar posts strong EBITDA growth and sharp debt reduction, returning to profitability in 2024.TG
Q4 20245 Jun 2025